Your browser doesn't support javascript.
loading
PITX2 deficiency leads to atrial mitochondrial dysfunction.
Reyat, Jasmeet S; Sommerfeld, Laura C; O'Reilly, Molly; Cardoso, Victor R; Thiemann, Ellen; Khan, Abdullah O; O'Shea, Christopher; Harder, Sönke; Müller, Christian; Barlow, Jonathan; Stapley, Rachel J; Chua, Winnie; Kabir, S Nashitha; Grech, Olivia; Hummel, Oliver; Hübner, Norbert; Kääb, Stefan; Mont, Lluis; Hatem, Stéphane N; Winters, Joris; Zeemering, Stef; Morgan, Neil V; Rayes, Julie; Gehmlich, Katja; Stoll, Monika; Brand, Theresa; Schweizer, Michaela; Piasecki, Angelika; Schotten, Ulrich; Gkoutos, Georgios V; Lorenz, Kristina; Cuello, Friederike; Kirchhof, Paulus; Fabritz, Larissa.
Afiliação
  • Reyat JS; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Sommerfeld LC; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • O'Reilly M; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Cardoso VR; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Thiemann E; DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, University Medical Center Hamburg-Eppendorf, Germany.
  • Khan AO; University Center of Cardiovascular Sciences, University Medical Center Hamburg-Eppendorf, Germany.
  • O'Shea C; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Harder S; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Müller C; Institute of Cancer Genomics, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Barlow J; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Stapley RJ; DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, University Medical Center Hamburg-Eppendorf, Germany.
  • Chua W; Institute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
  • Kabir SN; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Grech O; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Hummel O; Institut für Klinische Chemie und Laboratoriumsmedizin, Massenspektrometrische Proteomanalytik, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
  • Hübner N; UKE Bioinformatics Core; University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
  • Kääb S; Cellular Health and Metabolism Facility, College of Life and Environmental Sciences, University of Birmingham, Birmingham, UK.
  • Mont L; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Hatem SN; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Winters J; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Zeemering S; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Morgan NV; Max Delbrück Centrum for Molecular Medicine, Berlin, Germany, Charite - Universitätsmedizin Berlin, German, and German Center for Cardiovascular Research (DZHK), partner site Berlin.
  • Rayes J; Charite - Universitätsmedizin Berlin, Germany.
  • Gehmlich K; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.
  • Stoll M; Department of Medicine I, University Hospital Munich, Ludwig Maximilian University of Munich (LMU), Munich, Germany.
  • Brand T; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
  • Schweizer M; Hospital Clínic, Universitat de Barcelona, Catalonia, Spain and Institut de Recerca Biomèdica, August Pi- i Sunyer, Barcelona, Catalonia, Spain.
  • Piasecki A; Centro Investigación Biomedica en Red Cardiovascular, Madrid, Spain.
  • Schotten U; INSERM UMRS1166, ICAN - Institute of Cardiometabolism and Nutrition, Sorbonne University, Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.
  • Gkoutos GV; Cardiovascular Research Institute Maastricht, Department of Physiology, Maastricht University, Maastricht, The Netherlands.
  • Lorenz K; Cardiovascular Research Institute Maastricht, Department of Physiology, Maastricht University, Maastricht, The Netherlands.
  • Cuello F; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Kirchhof P; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
  • Fabritz L; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
Cardiovasc Res ; 2024 Aug 12.
Article em En | MEDLINE | ID: mdl-39129206
ABSTRACT

AIM:

Reduced left atrial PITX2 is associated with atrial cardiomyopathy and atrial fibrillation. PITX2 is restricted to left atrial cardiomyocytes in the adult heart. The links between PITX2 deficiency, atrial cardiomyopathy and atrial fibrillation are not fully understood. METHODS AND

RESULTS:

To identify mechanisms linking PITX2 deficiency to atrial fibrillation, we generated and characterized PITX2-deficient human atrial cardiomyocytes derived from human induced pluripotent stem cells (hiPSC) and their controls. PITX2-deficient hiPSC-derived atrial cardiomyocytes showed shorter and disorganised sarcomeres and increased mononucleation. Electron microscopy found an increased number of smaller mitochondria compared to the control. Mitochondrial protein expression was altered in PITX2-deficient hiPSC-derived atrial cardiomyocytes. Single-nuclear RNA-sequencing found differences in cellular respiration pathways and differentially expressed mitochondrial and ion channel genes in PITX2-deficient hiPSC-derived atrial cardiomyocytes. PITX2 repression in hiPSC-derived atrial cardiomyocytes replicated dysregulation of cellular respiration. Mitochondrial respiration was shifted to increased glycolysis in PITX2-deficient hiPSC-derived atrial cardiomyocytes. PITX2-deficient human hiPSC-derived atrial cardiomyocytes showed higher spontaneous beating rates. Action potential duration was more variable with an overall prolongation of early repolarization, consistent with metabolic defects. Gene expression analyses confirmed changes in mitochondrial genes in left atria from 42 patients with atrial fibrillation compared to 43 patients in sinus rhythm. Dysregulation of left atrial mitochondrial (COX7C) and metabolic (FOXO1) genes was associated with PITX2 expression in human left atria.

CONCLUSIONS:

In summary, PITX2 deficiency causes mitochondrial dysfunction and a metabolic shift to glycolysis in human atrial cardiomyocytes. PITX2-dependent metabolic changes can contribute to the structural and functional defects found in PITX2-deficient atria.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cardiovasc Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cardiovasc Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido